{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:09:36Z","timestamp":1793254176949,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bpobgyn.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:50:20Z","timestamp":1484959820000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The current status of hormonal therapies for heavy menstrual bleeding"],"prefix":"10.1016","volume":"40","author":[{"given":"Oskari","family":"Heikinheimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0010-7824(92)90095-B","article-title":"The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status","volume":"46","author":"Larsson","year":"1992","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.01.001_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.contraception.2015.01.008","article-title":"A\u00a0review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women","volume":"91","author":"Dinh","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1701-2163(16)34151-2","article-title":"A\u00a0Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia","volume":"31","author":"Endrikat","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.01.001_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2010.06.011","article-title":"Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial","volume":"83","author":"Shaaban","year":"2011","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.01.001_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.contraception.2011.07.012","article-title":"Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone","volume":"85","author":"Abu Hashim","year":"2012","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.01.001_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.01.001_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0b013e318250c3a0","article-title":"Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17\u03b2-estradiol: a randomized controlled trial","volume":"119","author":"Westhoff","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.01.001_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.contraception.2011.11.011","article-title":"Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate\/dienogest","volume":"86","author":"Fraser","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.01.001_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jadohealth.2006.09.013","article-title":"Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices","volume":"40","author":"Gerschultz","year":"2007","journal-title":"J\u00a0Adolesc Health"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.01.001_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001016.pub2","article-title":"Cyclical progestogens for heavy menstrual bleeding","author":"Lethaby","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.bpobgyn.2017.01.001_bib11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1471-0528.1998.tb10172.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia","volume":"105","author":"Irvine","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0010-7824(76)80036-4","article-title":"A\u00a0D-norgestrel-releasing IUD","volume":"13","author":"Nilsson","year":"1976","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0010-7824(77)90001-4","article-title":"Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device","volume":"15","author":"Nilsson","year":"1977","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.01.001_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.01.001_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9378(11)90533-X","article-title":"A\u00a0comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia","volume":"164","author":"Milsom","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.01.001_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00004347-198609000-00005","article-title":"Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices","volume":"5","author":"Silverberg","year":"1986","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.01.001_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/humrep\/13.5.1218","article-title":"Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery","volume":"13","author":"Critchley","year":"1998","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.01.001_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejogrb.2011.02.013","article-title":"Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing intrauterine system","volume":"157","author":"Engemise","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.01.001_bib19","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1093\/humrep\/deg510","article-title":"Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium","volume":"18","author":"Burton","year":"2003","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.01.001_bib20","first-page":"660","article-title":"Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium","volume":"75","author":"Pekonen","year":"1992","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.01.001_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2006.02243.x","article-title":"The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic\/inhibitor systems in women with menorrhagia","volume":"5","author":"Koh","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"10.1016\/j.bpobgyn.2017.01.001_bib22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/humrep\/deg329","article-title":"The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium","volume":"18","author":"Roopa","year":"2003","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/humrep\/deg179","article-title":"Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis","volume":"18","author":"Laoag-Fernandez","year":"2003","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2017.01.001_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/AOG.0b013e3181ec622b","article-title":"Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Kaunitz","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.01.001_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2017.01.001_bib26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0b013e3181a1d3ce","article-title":"Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis","volume":"113","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"7138","key":"10.1016\/j.bpobgyn.2017.01.001_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bmj.316.7138.1122","article-title":"Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy","volume":"316","author":"L\u00e4hteenm\u00e4ki","year":"1998","journal-title":"BMJ"},{"issue":"9252","key":"10.1016\/j.bpobgyn.2017.01.001_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)03615-1","article-title":"Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial","volume":"357","author":"Hurskainen","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bpobgyn.2017.01.001_bib29","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.01.001_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003855.pub3","article-title":"Surgery versus medical therapy for heavy menstrual bleeding","author":"Marjoribanks","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.01.001_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/OGX.0000000000000155","article-title":"Medical management of heavy menstrual bleeding: a comprehensive review of the literature","volume":"70","author":"Bitzer","year":"2015","journal-title":"Obstetrical Gynecol Surv"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002126.pub3","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2017.01.001_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejogrb.2014.04.024","article-title":"Hysterectomy rates for benign conditions are declining in Lombardy, Italy: 1996\u20132010","volume":"178","author":"Parazzini","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2017.01.001_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ajo.12477","article-title":"Recent estimates of the incidence of hysterectomy in New South Wales and trends over the past 30 years","volume":"56","author":"Yusuf","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2017.01.001_bib35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-0528.2005.00642.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts","volume":"112","author":"Reid","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2017.01.001_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1701-2163(15)30939-7","article-title":"Society of Obstetricians and Gynaecologists of Canada. Abnormal uterine bleeding in pre-menopausal women","volume":"35","author":"Singh","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.bpobgyn.2017.01.001_bib37","unstructured":"www.kaypahoito.fi\/web\/kh\/suositukset\/suositus?id=hoi50033. [Date last assessed 19 August 2016]."},{"issue":"2","key":"10.1016\/j.bpobgyn.2017.01.001_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejogrb.2010.07.016","article-title":"Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause","volume":"152","author":"Marret","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2017.01.001_bib39","unstructured":"www.nice.org.uk\/guidance\/cg44\/chapter\/1-Guidance#choice. [Date last assessed 19 August 2016]."},{"issue":"1","key":"10.1016\/j.bpobgyn.2017.01.001_bib40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000431815.52679.bb","article-title":"Management of abnormal uterine bleeding associated with ovulatory dysfunction -practice bulletin","volume":"122","author":"American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstetrics Gynecol"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417300020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693417300020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T19:25:13Z","timestamp":1536089113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693417300020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":40,"alternative-id":["S1521693417300020"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.01.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732192753.793539725","asserted-by":"object"}]},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current status of hormonal therapies for heavy menstrual bleeding","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}